Skip to main content
Premium Trial:

Request an Annual Quote

SeraCare's Seraseq Myeloid Mutation DNA Mix and Myeloid RNA Fusion Mix

SeraCare Life Sciences has launched next-generation sequencing reference material for hematologic malignancies. The Seraseq Myeloid Mutation DNA Mix and Myeloid RNA Fusion Mix include mutation types from SNVs to gene fusions. The products contain 23 DNA mutations and nine fusion RNAs that are present against a well-characterized genomic background at clinically relevant allele frequencies. The products are designed to help clinical labs that perform NGS-based testing of myeloid malignancies to characterize their assays.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.